BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29776959)

  • 21. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the Cox-maze procedure for atrial fibrillation concomitant to mitral and tricuspid valve surgery.
    Ad N; Holmes SD; Massimiano PS; Pritchard G; Stone LE; Henry L
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1426-34; discussion 1434-5. PubMed ID: 24075462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation.
    Ad N; Henry L; Hunt S; Stone L
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1146-52. PubMed ID: 20412955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals.
    Stiell IG; Clement CM; Rowe BH; Brison RJ; Wyse DG; Birnie D; Dorian P; Lang E; Perry JJ; Borgundvaag B; Eagles D; Redfearn D; Brinkhurst J; Wells GA
    Ann Emerg Med; 2017 May; 69(5):562-571.e2. PubMed ID: 28110987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
    Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
    Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimally Invasive Stand-Alone Cox Maze Procedure for Persistent and Long-Standing Persistent Atrial Fibrillation: Perioperative Safety and 5-Year Outcomes.
    Ad N; Holmes SD; Friehling T
    Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29138143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
    Proietti M; Laroche C; Nyvad O; Haberka M; Vassilikos VP; Maggioni AP; Boriani G; Lip GYH;
    Int J Cardiol; 2017 Dec; 248():166-172. PubMed ID: 28859841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact force-sensing catheter: real-world experience from a prospective, multicentre observational cohort registry.
    De Potter T; Van Herendael H; Balasubramaniam R; Wright M; Agarwal SC; Sanders P; Khaykin Y; Latcu DG; Maury P; Pani A; Hayes J; Kalman J; Nery P; Duncan E
    Europace; 2018 Nov; 20(FI_3):f410-f418. PubMed ID: 29315382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study.
    Camm AJ; Turpie AGG; Hess S; Amarenco P; Lambelet M; Haas S; van Eickels M; Kirchhof P;
    Europace; 2018 Jun; 20(6):e87-e95. PubMed ID: 29016755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
    Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke prevention following modified endoscopic ablation and appendectomy for atrial fibrillation.
    Ma N; Jiang Z; Chen F; Yin H; Ding F; Mei J
    Heart Vessels; 2016 Sep; 31(9):1529-36. PubMed ID: 26391680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation.
    Tsadok MA; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Humphries KH; Tu JV; Behlouli H; Pilote L
    Circulation; 2012 Dec; 126(23):2680-7. PubMed ID: 23124034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of sinus rhythm after electrical cardioversion for recurrent atrial fibrillation following mitral valve surgery with or without associated radiofrequency ablation.
    van Breugel HN; Gelsomino S; de Vos CB; Accord RE; Tieleman RG; LucĂ  F; Rostagno C; Renzulli A; Parise O; Lorusso R; Crijns HJ; Maessen JG
    Int J Cardiol; 2014 Aug; 175(2):290-6. PubMed ID: 24882697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours.
    Weigner MJ; Caulfield TA; Danias PG; Silverman DI; Manning WJ
    Ann Intern Med; 1997 Apr; 126(8):615-20. PubMed ID: 9103128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhythm control in atrial fibrillation.
    Piccini JP; Fauchier L
    Lancet; 2016 Aug; 388(10046):829-40. PubMed ID: 27560278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.